DNAnexus Appoints David Fenstermacher as Vice President of Precision Medicine and Data Sciences
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--May 20, 2019--
DNAnexus, Inc., the leader in biomedical informatics and data management, today announced the appointment of David Fenstermacher, PhD, as Vice President of Precision Medicine and Data Services. Dr. Fenstermacher will be responsible for overseeing the company’s data management solutions for precision health and drug discovery applications at leading cancer centers, academic institutions, healthcare providers, and pharmaceutical companies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190520005164/en/
David Fenstermacher, PhD (Photo: Business Wire)
“David is recognized as one of the most esteemed biomedical informaticians in the world, and we are proud to add him to the growing DNAnexus team,” said Richard Daly, Chief Executive Officer of DNAnexus. “As a former precision medicine researcher and user of the DNAnexus Platform, David brings a deep and valuable understanding of how DNAnexus can help solve the complex precision health and drug discovery challenges that our customers face on a daily basis.”
Dr. Fenstermacher brings more than 30 years of research experience as a molecular biologist and bioinformatician. During his career, he has designed and directed the implementation of numerous biomedical informatics distributed computing systems to support basic, translational, and clinical research, including multi-institution research projects. He has also designed data warehouses that integrate patient-level clinical data and other ’omics data to support studies focused on cancer and other human diseases.
Prior to joining DNAnexus, Dr. Fenstermacher was the Vice President of R&D Bioinformatics at MedImmune. He also served as the Chief Research Information Officer for Virginia Commonwealth University and was Founding Chair of the Department of Biomedical Informatics at the H. Lee Moffitt Cancer Center. Dr. Fenstermacher received his Bachelor of Science from Bloomsburg University of Pennsylvania and his PhD in molecular biology and genetics from the University of North Carolina at Chapel Hill.
“DNAnexus has long been at the forefront of scalable genomic analysis in this era of precision medicine, and its cloud-based technology platform continues to unlock numerous landmark discoveries,” said Dr. Fenstermacher. “I am thrilled to join this accomplished team and look forward to tackling exciting opportunities in human health by making it easier for more partners around the world to accelerate disease diagnosis, develop more effective treatments, and improve patient outcomes.”
DNAnexus, the leader in biomedical informatics and data management, has created the global network for genomics and other biomedical data, operating in 33 countries across North America, South America, Europe, Asia, Australia, and Africa. The secure, scalable, and collaborative DNAnexus Platform helps thousands of researchers across a spectrum of industries – biopharmaceutical, bioagricultural, sequencing services, clinical diagnostics, government, and research consortia – accelerate their genomics programs. For more information on DNAnexus, please visit www.dnanexus.com or follow the company @DNAnexus.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190520005164/en/
CONTACT: Andrew Noble
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: TECHNOLOGY DATA MANAGEMENT HEALTH BIOTECHNOLOGY GENETICS RESEARCH SCIENCE
SOURCE: DNAnexus, Inc.
Copyright Business Wire 2019.
PUB: 05/20/2019 08:00 AM/DISC: 05/20/2019 08:01 AM